Connect with us

Funding

Tvaster Genkalp secures $1.25 million from Ideaspring Capital

Published

on

[ad_1]

Tvaster Genkalp, a molecular diagnostics firm, has raised $1.25 million in a pre-series A funding round led by Ideaspring Capital.

Existing investors include Invigo Softwares and Prof Mohamed Rela, a liver transplant surgeon. The fresh investment will accelerate expansion and commercialisation of Episcreen Liver, a methylation-based liquid biopsy test for early liver cancer detection.

Co-founded in 2021 by Dr Srikar Raman and K Sreedurgalakshmi, Tvaster is into molecular diagnostics and precision oncology through epigenetic screening technologies.

[ad_2]

Source link

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply